Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

被引：0
|
作者：
Luca Manetti
Timo Deutschbein
Jochen Schopohl
Kevin C. J. Yuen
Michael Roughton
Ulrike Kriemler-Krahn
Libuse Tauchmanova
Ricardo Maamari
Carla Giordano
机构：
[1] Università di Pisa,Azienda Ospedaliero
[2] University of Würzburg,Universitaria Pisana, Dipartimento di Medicina Clinica e Sperimentale
[3] Ludwig-Maximilians-Universität München,Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital
[4] Swedish Neuroscience Institute,Medizinische Klinik und Poliklinik IV
[5] Barrow Neurological Institute,Swedish Pituitary Center
[6] Novartis Pharma AG,Section of Endocrinology, Diabetology and Metabolism, Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialities (PROMISE)
[7] Novartis Pharmaceuticals Corporation,undefined
[8] University of Palermo,undefined
来源：
Pituitary | 2019年 / 22卷
关键词：
Cushing’s disease; Pasireotide; Hypercortisolism; Pituitary; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：542 / 551
页数：9
相关论文
共 50 条
  • [21] Long-term Medical Treatment of Cushing's Disease with Pasireotide: A Review of Current Evidence and Clinical Experience
    Samson, S. L.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (08) : 445 - 450
  • [22] Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
    Petersenn, Stephan
    Farrall, Andrew J.
    Block, Christophe
    Melmed, Shlomo
    Schopohl, Jochen
    Caron, Philippe
    Cuneo, Ross
    Kleinberg, David
    Colao, Annamaria
    Ruffin, Matthieu
    Resendiz, Karina Hermosillo
    Hughes, Gareth
    Hu, Ke
    Barkan, Ariel
    PITUITARY, 2014, 17 (02) : 132 - 140
  • [23] Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
    Stephan Petersenn
    Andrew J. Farrall
    Christophe Block
    Shlomo Melmed
    Jochen Schopohl
    Philippe Caron
    Ross Cuneo
    David Kleinberg
    Annamaria Colao
    Matthieu Ruffin
    Karina Hermosillo Reséndiz
    Gareth Hughes
    Ke Hu
    Ariel Barkan
    Pituitary, 2014, 17 : 132 - 140
  • [24] Efficacy and safety of ixekizumab in psoriatic patients: a long-term real-world retrospective multicentre study from Southern Italy
    Musumeci, Maria Letizia
    Trecarichi, Andrea Calogero
    Megna, Matteo
    Potestio, Luca
    Micali, Giuseppe
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2025,
  • [25] Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study
    Hadden, R.
    Andersen, H.
    Bril, V.
    Basta, I.
    Rejdak, K.
    Djordjevic, G.
    Greco, E.
    Hasan, S.
    French, J.
    Yel, L.
    Ay, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 286 - 286
  • [26] Long-term Results of Total Adrenalectomy for Cushing's Disease
    Suresh K. Nagesser
    Arnoud P. van Seters
    Job Kievit
    Jo Hermans
    H. Michiel J. Krans
    Cornelis J.H. van de Velde
    World Journal of Surgery, 2000, 24 : 108 - 113
  • [27] Long-term results of total adrenalectomy for Cushing's disease
    Nagesser, SK
    van Seters, AP
    Kievit, J
    Hermans, J
    Krans, HMJ
    van de Velde, CJH
    WORLD JOURNAL OF SURGERY, 2000, 24 (01) : 108 - 113
  • [28] Long-Term, Real-World Safety of Adalimumab in Rheumatoid Arthritis
    Harrold, Leslie R.
    Griffith, Jenny
    Litman, Heather J.
    Gershenson, Bernice
    Islam, Syecl
    Barr, Christine J.
    Guo, Dianlin
    Zueger, Patrick
    Fay, Jonathan
    Greenberg, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [29] Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry
    Iborra, Marisa
    Beltran, Belen
    Fernandez-Clotet, Agnes
    Iglesias-Flores, Eva
    Navarro, Pablo
    Rivero, Montserrat
    Gutierrez, Ana
    Sierra-Ausin, Monica
    Mesonero, Francisco
    Ferreiro-Iglesias, Rocio
    Hinojosa, Joaquin
    Calvet, Xavier
    Sicilia, Beatriz
    Gonzalez-Munoza, Carlos
    Antolin, Beatriz
    Gonzalez-Vivo, Maria
    Carbajo, Ana Y.
    Garcia-Lopez, Santiago
    Martin-Cardona, Albert
    Suris, Gerard
    Dolores Martin-Arranz, Maria
    de Francisco, Ruth
    Canete, Fiorella
    Domenech, Eugeni
    Nos, Pilar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1017 - 1030
  • [30] Real-world long-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA registry
    Iborra Colomino, M. I.
    Beltran, B.
    Fernandez-Clotet, A.
    Iglesias Flores, E.
    Navarro, P.
    Rivero, M.
    Gutierrez, A.
    Sierra-Ausin, M.
    Mesonero, F.
    Ferreiro-Iglesias, R.
    Hinojosa, J.
    Calvet, X.
    Sicilia, B.
    Gonzalez-Munoza, C.
    Antolin, B.
    Gonzalez Vivo, M.
    Carbajo, A. Y.
    Garcia, S.
    Martin-Cardona, A.
    Suris Marin, G.
    Martin-Arranz, M. D.
    De Francisco, R.
    Canete, F.
    Carlos, T.
    Gomollon, F.
    Lorente, R.
    Rodriguez-Lago, I.
    Fores-Bosch, A.
    Bernardos, E.
    Ramos, L.
    Delgado, P.
    Hernandez, A.
    Van Domselaar, M.
    Hervas, D.
    Domenech, E.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S458 - S460
12345